Cerebral vasculature imaging is required in the diagnosis of cerebrovascular pathology and healthcare stakeholders are increasingly interested in safer, cheaper and higher resolution clinical imaging solutions. In the last decade, the field of nanotechnology has exploded, and new nanomedicine and nanoneuromedicine approaches have been proposed as alternative or complementary solutions to already existing vasculature imaging tools (e.g., MRI-and/or CT-based angiography).
Several metallic and organic nanomaterials have been approved by the US FDA at different clinical trial stages as diagnostic tools; semiconductor nanomaterials (for example, quantum dots) are, on the other hand, generally considered for research use only [1, 2] . Recently, a new generation of fluorescent silica nanoparticles called Cornell dots (C-dots), with efficient urinary excretion [3] and effective cancer-targeting properties [4, 5] , received FDA approval for clinical use. This FDA approval opens a new era for nanomedicine, and deeper understanding of cell-specific action of semiconductor-based nanoparticles is urgently needed.
Rapid nanotechnology advances in preclinical brain vasculature imaging [6] [7] [8] [9] [10] have substantially increased our ability to unveil vascular contributions to the pathogenesis of brain ischemia, brain tumor formation, Alzheimer disease and epilepsy [11] [12] [13] .
Quantum-dot nanoparticles (QDs) gained popularity over the last decade [14] , due to their superior optical properties with respect to conventional organic dyes [15] [16] [17] . In particular, Qtracker ® vascular labels (Qtracker ® 565, Qtracker ® 605, Qtracker ® 655, Qtracker ® 705 and Qtracker ® 800, named according to their emission wavelength) have been designed for in vivo deep-tissue imaging of blood vessel distribution and morphological properties in small animals [18] . The high-wavelength Qtracker ® 800 allows the deepest imaging of tissue vasculature of the series. Preclinical in vivo imaging studies of the vessels using Qtracker ® 800 have already been carried out Research Article Radu, Radu, Tognoli et al. to highlight mouse tumor vascularization [19] and bone marrow vasculature [20] .
Biocompatibility is a key requirement for QD-based in vivo vascular imaging. The 'ideal' QDs should be 'inert' with respect to the microenvironment (e.g., circulating and endothelial cells). In practice, this desired property is usually sought by coating the QDs with a thin polymer layer, one of the most used being PEG, without any functional group. This layer reduces the nonspecific interaction of coated QDs with the surrounding molecular species, including those present on the cell plasma membrane [18, 21] . Indeed, PEG coating of QDs drastically minimizes nonspecific interactions [18] and decreases cellular uptake rate, as proved in three tumor cell lines [22] .
A very recent report, however, demonstrated the uptake of PEG-coated silica nanoparticles in brain endothelial cells [23] . Since these coated nanoparticles are between 25 and 100 nm (i.e., almost five-to tentimes the core diameter of QDs) and given the authors' claim that nanoparticle transport across the bloodbrain barrier is size-dependent, we wondered whether PEG-coated QDs might show significant interactions with endothelial cells. To our knowledge, there are no published reports describing such direct interaction.
Based on these premises, we investigated: whether in vivo Qtracker ® 800 are uptaken by endothelial cells, and the functional consequences of endothelial exposure to Qtracker ® 800, studied in vitro. First, the hydrodynamic diameter of Qtracker ® 800 was estimated by dynamic light scattering (DLS) and the core size was calculated from electron microscopy images in order to characterize the nanoparticles. Next, in a set of in vivo experiments, Qtracker ® 800 uptake in mouse brain endothelia was investigated by electron microscopy. As previously described, many aspects of vascular endothelium physiology are regulated by calcium signaling pathways, since most of the stimuli relaxing or contracting brain capillaries act directly on the endothelial cells, producing changes in intracellular-free calcium concentration [24] [25] [26] . Based on the above, we also investigated in vitro the ability of a Qtracker ® 800 flux to induce fluctuations of free cytosolic calcium concentration and/or changes in mouse brain endothelial cell viability. We have also extended our in vitro study to another type of endothelial cells (human umbilical vein endothelial cells [HUVECs] ) in order to discriminate between a specific effect on mouse brain endothelial cells and an ubiquitous effect.
Materials & methods

Chemicals
Qtracker
® 800 (Q21071MP, lot #1216103, Life technologies, NY, USA) were dissolved in 0.9% saline solution for the in vivo studies, and in Ringer HEPES-buffered solution (NaCl: 140 mM; KCl: 5.6 mM; MgCl 2 : 2 mM; CaCl 2 : 2 mM; glucose: 10 mM; HEPES 10 mM; pH 7.4 with NaOH) or phosphate-buffered solution (5 mM; pH 7.4) for the in vitro experiments. Fura-2 acetoxymethyl ester (Fura-2 AM) and pluronic acid F-127 (Life technologies) were dissolved in Ringer solution. All other reagents were purchased from Sigma-Aldrich (MO, USA).
Hydrodynamic size measurements by DLS DLS was performed on Qtracker ® 800 using a Zetasizer Nano ZS instrument (Malvern Instruments Ltd, MA, USA) operating with a 633 nm He-Ne laser light source and a fixed detector angle of 173°, as previously described [27] . Qtracker ® 800, 2-μM stock solution of 2 μM in 50 mM borate buffer, pH 8.3 (Life Technologies) was diluted to the range of 40-80 nM either in Ringer solution or in saline solution (See section Chemicals). Lower particle concentrations resulted in poor signal/noise and large fit errors (using either single or multiple exponential models). Hydrodynamic diameter values were determined by averaging the intensity-weighted size distributions obtained from 20 successive DLS runs of 10 s each. Measurements were repeated three-times and results are reported as mean ± standard deviation (SD). The distribution widths were quantified by the Polydispersity Index (PdI). DLS measurements were carried out at 25°C before and after filtration (through acetate-cellulose Costar Spin-X Centrifuge Tube Filters, 0.22 μm pore size, Cole Parmer, USA) or centrifugation (18,000 × g for 15 min) of Qtracker ® 800 solutions. No filtration or centrifugation were used on the Qtracker ® 800 solutions employed for the in vivo and in vitro experiments.
Zeta potential measurements
Measurements were performed with a Zetasizer Nano ZS instrument (Malvern Instruments Ltd.). Qtracker ® 800 particles were dispersed at a final concentration of 75 nM in phosphate buffer, pH 7.4 and transferred to a disposable zeta cell. Measurements were carried out at 25°C after 120 s equilibration time, performing seven runs comprising 12 subruns each. The applied voltage was 100 V and the measured conductibility was 4.540 ± 0.334 mS cm -1 . All measurements passed technical quality criteria based on inspection of phase and frequency plots, and were reproducible after sample spinning at 18,000 × g for 15 min. Zeta potential was evaluated from electrophoretic mobility applying the Henry equation.
Animals & QD injection
Male Balb/c mice acquired from Harlan-Nossan (Udine, Italy) were adapted to the laboratory and future science group Brain endothelial cells are activated by QDs Research Article maintained on a 12-h inverted light/dark cycle, at 23 ± 1°C, with access to food and water ad libitum. Experiments started when animals were 6 weeks old and weighed 25 ± 5 g.
Experiments were approved by the University of Verona ethical committee. Animals (n = 10) were divided into two equal groups, one received injection of saline solution and the other of Qtracker ® 800, and both groups were sacrificed 3 h after injection.
Qtracker ® 800 solutions (or saline) were administered through a single injection (0.4 μM, 10 μl/g for each mouse) into the tail vein. Mice were then deeply anesthetized (zolazepam and tiletamine, ip. 20 mg/ kg), and perfused transcardially with PBS followed by phosphate-buffered 4% paraformaldehyde. Cortical brain samples were collected to evaluate Qtracker ® 800 presence in the endothelium, based on transmission electron microscopy (TEM) and immunohistochemistry analysis.
According to the recommendation of the producer, the optimal time-interval for in vivo vasculature imaging with Qtracker ® 800 is 3 h post-injection [18] . Therefore, the 3-h time point is essential in understanding Qtracker ® 800 distribution into the cerebral bloodstream and if this time interval is sufficient for the nanoparticles to interact with the mouse brain vascular endothelium.
Transmission electron microscopy
Brain tissue samples were fixed in 2% glutaraldehyde in Sorensen buffer pH 7.4 for 2 h, postfixed in 1% osmium tetroxide in aqueous solution (2 h), dehydrated in graded concentrations of acetone and embedded in Epon-Araldite mixture (Electron microscopy Sciences, PA, USA). Ultrathin tissue sections (70 nm) were placed on Cu/Rh grids with Ultracut E (Reichert, Wien, Austria) and were observed using a Morgagni 268D microscope (Philips, The Netherlands).
For imaging the Qtracker ® 800 in solution, a droplet of nanoparticle solution was put on the grid (FCF-150-Cu, Electron Microscopy Science, PA, USA) and, after drying, the grid was imaged without any other processing.
Human umbilical vein endothelial cell cultures
HUVECs from seven healthy donors were individually harvested as previously described [28] and used between passages 2 and 5. The medium was refreshed every 2 days. At the beginning of each experiment, cells were harvested by trypsinization, using 0.05% trypsin (Sigma-Aldrich) and 0.537 mM EDTA in phosphate-buffered saline without calcium and magnesium (Seromed, Berlin, Germany). Cells were plated at a density of 2 × 10 4 cells/cm 2 onto 24-mm cover glasses for intracellular calcium imaging measurements.
Mouse brain endothelial cell cultures
Primary cultures of brain microvascular endothelial cells (BMVECs from Balb/c mice, passage 3-6; #PB-BALB-5023, PELOBiotech, Germany) were cultivated according to the producer's protocol. bEnd.3 (passage 22-30; #ATCC ® CRL-2299 ™ , VA, USA), a Balb/c mouse cell line, was grown in DMEM with Glutamax-I, 10% fetal bovine serum (Gibco, NY, USA), 100 U/ml penicillin, 100 μg/ml streptomycin, 5% CO 2 (37°C). Cells were plated at a density of 2 × 10 4 cells/cm 2 onto 24-mm cover glasses for intracellular calcium imaging measurements or 96-well plates for viability assays.
In-vitro Qtracker
® 800 studies
In order to apply Qtracker ® 800 in vitro in concentrations comparable to those used for the in vivo studies, we first estimated that the above-described injections yielded blood concentrations around 44-nM nanoparticles, based on a mouse whole blood volume of approximately 2 ml [29] . Taking into account this approximate value and the range of concentrations previously reported for in vitro studies using Qtracker ® 655 [30] , we used between 10 and 40 nM Qtracker ® 800 in our in vitro experiments. To shed light on the Qtracker ® 800 direct action against brain microvascular endothelial cells, we performed calcium imaging and cell viability measurements on bEnd.3 cells and BMVECs.
Intracellular calcium imaging on endothelial cells
Fura-2 AM-based, Ca
2+ imaging experiments on endothelial cells were performed as previously described [31] . Images were captured using a cooled CCD camera (Clara, Andor, Northern Ireland) in a setup including a monochromator Polychrome V (Till Photonics, Germany) coupled to an inverted microscope (Diaphot 200, Nikon, Japan), and were acquired on a computer using an image acquisition software (Live Acquisition, Till Photonics, Germany). Solutions were delivered on top of the endothelial cells through a 100-μm quartz perfusion head using an 8-channel valve pressurized perfusion system (ALA Scientific Instruments, NY, USA). Cells were incubated with Fura-2 AM (2.5 μM) and pluronic acid (F-127, 0.01%) for 45 min. After 15 min, the necessary time for Fura-2AM de-esterification, the cells were imaged. Before starting the nanoparticle flux, the cell monolayer was perfused with Ringer HEPES-buffered for 5 min. Cytosolic Ca 2+ transients were elicited by the administration of 20 nM Qtracker ® 800 for 5 min followed, after a Ringer HEPES-buffered wash-out period of 10 min, by the application of either ATP (30 μM, 20 s) for BMVECs and bEnd.3 cells, or histamine (10 μM, 20 s) for HUVECs. ATP and histamine are topical vasoactive substances that regulate brain capillary blood flow and vascular permeability [24, 32] , and were therefore used as positive controls for evoking intracellular calcium transients in endothelial cells. Cells that did not show a response to the positive control were excluded from subsequent analyses.
Endothelial cell viability by Trypan blue assay
Trypan blue assay was performed on bEnd.3 and BMVECs in control conditions and after 24-h treatment with Qtracker ® 800 (10, 20 and 40 nM). Cells were detached by trypsin, trypan blue was added (0.2%) and viable cells were counted (at least 150 cells). The viability was calculated relative to controls. Measurements were done in three replicates. Cells exposed to 3 mM H 2 O 2 (1 h) were used as positive control.
Data analysis
Data analysis was performed using OriginPro 8 (OriginLab Corporation, MA, USA), Offline Acquisition software (Till Photonics, Germany) and Matlab (Mathworks, MA, USA).
Intracellular calcium changes were estimated from the ratio R = I 340 nm /I 380 nm (I 340 and I 380 are the intensities measured at the emission wavelength of 510 nm when Fura-2 was excited at 340 and 380 nm, respectively). The ratio R was calculated in regions of interest (ROIs) covering each cell in the microscope field, after background subtraction. R values were corrected by subtracting baseline signals averaged over the 5 min of perfusion prior to the application of nanoparticles. The resulting ΔR values were used for subsequent analyses. Only responses with an amplitude higher than three-times the SD of the background noise (measured before QDs administration) were considered.
In view of the lack of standard quantitative methods to describe calcium transients in the literature [26] , we defined a set of parameters characterising the signal envelope (Figure 1) . The onset and offset of the response were marked by the signal raising above and descending below a 5% threshold of the peak amplitude (ΔR max ). Response latency was the time from beginning of nanoparticle perfusion to response onset. Total response duration was the interval between response onset and offset. In order to differentiate between fast transients with sustained late responses and signals reaching a peak later in time, we computed a response asymmetry ratio (b/a), where a is the time from response onset to peak, and b is the time from response peak to offset. Total response area was the integral over response duration. Finally, we computed the maximum slope of the ascending transient (V max ). Pairwise correlations (along with Pearson and Spearman coefficients) among these parameters were computed with custom Matlab scripts. One-way ANOVAs followed by Fisher LSD post hoc tests were used to assess BMVEC and bEnd.3 endothelial cell viability, comparing cells treated with different concentrations of Qtracker ® 800 to untreated controls.
Results
Characterization of nanoparticles (size, hydrodynamic diameter & zeta-potential)
We measured the hydrodynamic diameter of Qtracker ® 800 by means of the DLS technique. DLS measurements were performed on QDs dissolved in saline solution or in Ringer HEPES-buffered solution.
For both saline and HEPES-buffered Ringer solutions, we found in the intensity distribution plots a major peak centered near the expected size of Qtracker ® 800 (Figure 2A & B) , as well as a minor peak corresponding to larger components (for example, aggregates of nanoparticles). The DLS graphs in Figure 2 refer to 50 nM Qtracker ® 800, but note that the distribution did not significantly change for the analyzed range of nanoparticle concentrations (40-80 nM). A global polydispersity index (PdI) of approximately 0.35 was determined for both solutions. The major, lower diameter peak can be attributed to isolated Qtracker ® 800 particles. Given the wider scattering of larger particles, the relative populations of the species corresponding to the two peaks can be better appreciated after conversion of the data into a number distribution (dotted lines), which results in a single peak and confirms the prevalence of well-dispersed Qtracker ® 800 particles. An attempt to remove the larger size contaminant by filtration was unsuccessful. On the other hand, centrifugation followed by DLS measurements on the supernatant resulted in very clean samples displaying a single peak in size distribution plots (Figure 2C &D) . The monomodal distribution observed for these two preparations allowed us to perform a rigorous cumulant analysis and evaluate the harmonic intensity-averaged particle diameter (Z-average). The Z-average of Qtracker ® 800 was 36.56 ± 0.13 nm in Ringer HEPES-buffer (PdI = 0.180) and 35.80 ± 0.34 nm in saline solution (PdI = 0.151). The zeta potential value was -0.0124 ± 0.206 mV, indicating that Qtracker ® 800 particles are essentially neutral at pH 7.4. Qtracker ® 800 were also characterized by TEM ( Figure 3A) and their cores, as visualized in suspension, were irregular in shape and their longest axis measured on average 8.27 ± 1.27 nm (SD). We then proceeded to evaluate the interaction of Qtracker ® 800 with the brain vascular endothelium in Balb/c mice upon nanoparticle injection. TEM analysis of mouse cortical brain sections indicated the presence of Qtracker ® 800 in the brain vascular endothelium 3 h after the intravenous injection, the time window recommended by the nanoparticle producer for vasculature imaging studies (Figure 3B & C) . Nanoparticles can be detected in the cytoplasm, both concentrated within vesicle-like structures, and free in the cytosol. An in-depth histological characterization (sampling different brain regions and cellular compartments, different time-points or even different organs) of the of Qtracker ® 800 nanoparticle distribution is beyond the scope of the present study. Acute (5 min) exposure to 20 nM Qtracker ® 800 generated cytosolic calcium transients in BMVECs (Figure 5A ), bEnd.3 cells ( Figure 5B ) and HUVECs ( Figure 5C & D) . Based on the inclusion criteria described above, we found that 13.7% (52/380 cells) of BMVECs and 13.9% (57/410 cells) of bEnd.3 cells were responsive to Qtracker ® 800. Out of a total 1796 studied HUVECs, 189 (or 10.5%) responded to Qtracker ® 800. Interestingly, the fraction of responsive cells varied significantly between the seven donors ( Figure 5D ), suggesting the possibility that subjects may be either sensitive (20% or more of responsive cells) or nonsensitive (5% or less) to nanoparticles.
ΔR max values induced by Qtracker ® 800 perfusion were on average a sizeable fraction of those induced in the positive control conditions. Namely, average ΔR max values for BMVEC and bEnd.3 cells were about ⅓ and ½, respectively, of those produced by ATP administration; HUVEC cells had an average ΔR max of about ⅔ of that induced by histamine administration ( Figure 5E ).
The quantitative analysis of calcium imaging recordings revealed a diversity of calcium transient profiles generated during the acute exposure of endothelial cells to the nanoparticle flux. The majority of observed calcium transients had a sharp onset, followed by a longer sustained response and decay (high asymmetry ratios). This pattern was substantially more marked in HUVECs than in mouse cells ( Figures 5A-C & 6A) .
In spite of certain commonalities, responses differed in several respects among cell types ( Figure 6A ). HUVEC transients showed the highest mean amplitude, area and duration ( Figure 6A ), in other words, they produced the strongest responses to nanoparticle administration. HUVEC transients were also highly asymmetrical (∼three-times more than the mouse endothelial transients). Interestingly, the ΔR max and V max distributions were remarkably similar. Indeed, a strong and highly significant correlation between the two parameters was observed ( Figure 6B , upper panels. See also Supplementary Figures 1-3 , Supplementary Material, for a complete presentation of the correlations and distribution histograms). This suggests that a very rapid increase in the ascending phase of the transient tends to produce high peak amplitudes. Even more important is the fact that the slope of the linear regression was very similar between On the other hand, response latencies were similar across endothelial cell types, again suggesting a common triggering mechanism. Additionally, an interesting pattern was observed when plotting response latencies against V max ( Figure 6B, lower panels) . The charts suggest that cells with relatively short latencies are characterized by a wide range of response transient velocities, while longer latencies were associated with relatively slower transients. In other words, delayed transients tended to be restricted to less steep ascending transients (smaller V max ) and consequently smaller amplitude. Brain endothelial cells are activated by QDs Research Article ticles can be uptaken in different cell types [30, [36] [37] [38] , but to our knowledge no reports are available for endothelial cells. Furthermore, uptake of Qtracker ® 800 has not been reported for any cell type.
Discussion
Endocytosis, which is thought to be the main pathway for nanoparticle internalization [39, 40] , depends on nanoparticle size [41] . Specifically, endocytosis-mediated uptake of nanoparticles was found to be more efficient for hydrodynamic diameter values around 50 nm [42] . In this respect, although the optical qualities of Qtracker ® 800 make it suitable for deep vasculature imaging, their high hydrodynamic diameter (∼35-36 nm based on our data) compared with the other dyes of the Qtracker ® vascular label series (the second largest being the 26.6 nm Qtracker 705 [43] ), makes them potentially more prone to endocytic internalization.
In in vivo or cell-culture experiments, the issue of nanoparticle fate is further complicated by the very complex media (blood, cell-culture medium) with which they interact. Very recent reports show the strong dependence of nanoparticle aggregation, particularly quantum dots, with respect to medium composition and coating structure [44, 45] . Even in a simpler solution, bovine serum albumin in PBS, the hydro- Brain endothelial cells are activated by QDs Research Article dynamic diameter of Qtracker ® 800, as measured by DLS, increased with albumin concentrations, becoming more than double at protein concentrations equivalent to those present in the mouse blood serum [46] . Blood fibrinogen was also proven to strongly bind Qtracker ® 800 [47] . In this context, it is very difficult to further speculate about the mechanism by which Qtracker ® 800 particles are uptaken into the cells. A vascular label such as the Qtracker ® nanoparticles is expected to be inert with respect to the physiology of the target system. Our study, however, shows that nontargeted, near-infrared emitting Qtracker ® 800 are captured by the brain vascular endothelium in the first 3 h upon vein injection, which raises important concerns, including the possibility that such uptake (and interaction more in general) may lead to alteration of endothelial cell functionality.
Qtracker
® 800 alters 'normal' calcium signaling in brain endothelial cells
It was previously shown that acute exposure (5-30 min) to non-PEGylated or functionalized QDs elicits in vitro cytosolic calcium increases in different excitable and nonexcitable cells [48] [49] [50] [51] . Our study points out that nanoparticle PEG-ylation, at least in the case of Qtracker ® 800, does not prevent functional consequences on the vascular endothelium, as revealed by the occurrence of calcium transients during the 5-min exposure.
The vascular endothelium has mechanosensitive properties, as part of the adaptation to the permanent shear stress exerted by the bloodstream. Endothelial cells may react to mechanical stimuli through a variety of mechanisms, such as transient receptor potential channels, ATP-operated cation channels, GTP-binding protein coupled receptors and adhesion molecules [52] . In turn, a variety of downstream intracellular signaling pathways are activated, the majority involving either calcium release from internal stores, the intake of extracellular calcium or both [51, 53] . The strong positive correlation between calcium release amplitude (ΔR max ) and steepness (V max ) shown in the present study has similarities with the previously reported amplitude-dependent calcium release in response to local mechanical stimuli [54] and might imply that Qtracker ® 800 act as a mechanical trigger for the calcium-induced transients.
The wide range of calcium event latencies we have observed, and the fact that only a subset of cells were activated, lead to the following speculation. Some cells are triggered by a probabilistic, direct interaction with the nanoparticles (possibly of mechanical nature) while neighboring cells are indirectly recruited in a wave of calcium events through intercellular communication mechanisms, as previously described in other endothelial cell types [55] . In this view, while fast and steep transients could be the result of direct nanoparticle-tocell interactions, slower and shallower transients could be related to indirect activations.
® 800 might activate different components of the neurovascular unit It has already been stated that brain microvascular endothelium is a major component of the neurovascular unit, playing essential roles in physiological and pathological neuronal-activation states [11, 56, 57] . The spatio-temporal Ca 2+ dynamics contribute to many physiological properties of the vascular intima [26] ; asynchronous and synchronous Ca 2+ waves control vascular tone [58] . Local changes at the level of vascular endothelium (e.g., leukocyte-endothelial adhesion, leukocyte rolling) can translate into alterations of neuronal excitability [11] . In this general context, the Qtracker ® 800-induced intracellular endothelial Ca 2+ transient activation shown by our results deserves attention in nanomedicine, and might imply not only localised endothelial Ca 2+ events but also the initiation of a complex signaling pathway involving multiple components of the neurovascular unit. Previous studies have highlighted the action of nanoparticles on different components of the neurovascular unit, by demonstrating that Qtracker ® 705: accumulate in vitro in primary cortical cultures; activates astrocytes after microinjection in brain cortex [36] . Furthermore, large silica (NH 2 ) PEGylated nanoparticles in vitro are uptaken into bEnd.3 cells and, in vivo, are transported across the blood-brain barrier in Balb/c mice [23] . Our results indicate that the nanoparticle-induced endothelial activation is not specific to mouse brain vessels, but it extends at least to a different species (human) and a different endothelial cell localization (umbilical vein). A further generalization of the observation will require ad hoc studies on endothelial cells derived from other species and organs.
A key result in our study is the striking difference in HUVEC sensitivity to Qtracker ® 800 from one donor to another (almost an all-or-none effect). Our data agree with previously reported donor-dependent variability of HUVECs exposed to laminar shear stress [59] , and might have implications for the use of near-infrared-emitting quantum dots in clinical vascular imaging applications.
Whether a similar donor-dependent variability of responses in HUVECs exists also in rodents is not easy to establish, since in vitro studies make use of sample pooling between several subjects (approximately ten mice for a single culture [60] ). But this is a relevant issue, because if on one hand the mean number of activated cells in mice and in humans are comparable (13.7 vs 10.5%) establishing potential effects based on such averages might underestimate the effects on the individuals more prone to QD-induced activations.
Conclusion & future perspective
Our study partly fills the knowledge gap regarding the interaction of near-infrared-emitting Qtracker ® 800 nanoparticles with biological systems, in particular the brain vascular endothelium. Both in vitro and in vivo data indicate the accumulation of QDs in the vascular endothelium as well as functional effects revealed by intracellular calcium changes in a subset of cells. In addition, we observed substantial interindividual differences in HUVEC activation. Altogether, the findings raise two types of concern: in studies of vascular function in living animals, the use of QD-based labeling might bias the results in difficult-to-detect ways; in view of possible clinical applications, the between-subject variability in susceptibility may complicate safety assessments.
Undoubtedly, brain vasculature imaging techniques can greatly benefit from the use of nanoparticle labels. On the other hand, as we have shown, such labels may be internalized by and functionally interact with blood vessel endothelia, which raises obvious safety concerns. It is quite possible that the effects uncovered represent the tip of an iceberg, and that further studies are necessary to better characterize the full extent and consequences of the activations. Ideally, the development of novel labels should be focused on reducing or eliminating their interactions with biological tissues. Considering the vast potential of these nanoparticles for brain vasculature imaging, we hope that further chemical engineering will optimize their biostability, biocompatibility and efficient clearance profile.
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Executive summary
Aim
• To assess the possible interaction of Qtracker ® 800 Vascular labels (Qtracker ® 800), a powerful nanotechnology tool for biomedical vasculature imaging, with mouse and human endothelium.
Results
• Transmission electron microscopy showed Qtracker ® 800 accumulation in mouse brain microvascular endothelium 3 h after their administration.
• Mouse brain endothelial cells, both in primary and immortalized cultures, are Qtracker ® 800-sensitive; 14% of cells generate intracellular calcium transients during acute 5-min exposures.
• Human umbilical vein endothelial cells in primary culture derived from different donors present substantial variability in transient calcium responses (0 ÷ 30%) when acutely exposed to Qtracker ® 800.
• The chronic in vitro exposure to Qtracker ® 800 for 24 h did not reveal major changes in endothelial cell viability.
Conclusion & future perspective
• We demonstrated a direct action of Qtracker ® 800 on the vascular endothelium in the first 3 h after administration, thus overlapping the time window recommended for vasculature imaging studies with these fluorescent nanoparticles.
• Keeping in mind the enormous potential of Qtracker ® 800 deep-tissue penetration in biomedical applications, better manufacturing solutions to diminish/eliminate endothelium actions should be found.
